The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line pembrolizumab plus chemotherapy versus chemotherapy in patients with advanced esophageal cancer: Chinese subgroup analysis of KEYNOTE-590.
 
Zhigang Li
No Relationships to Disclose
 
Yubei Sun
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Dong Ma
No Relationships to Disclose
 
Xianli Yin
No Relationships to Disclose
 
Wu Zhuang
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Yiping Zhang
No Relationships to Disclose
 
Kangsheng Gu
No Relationships to Disclose
 
Kuaile Zhao
No Relationships to Disclose
 
Juxiang Xiao
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Suxia Luo
No Relationships to Disclose
 
Liwei Wang
No Relationships to Disclose
 
Cailian Wang
No Relationships to Disclose
 
Yi Cui
Employment - Merck Sharp & Dohme
 
Lingling Mei
Employment - Merck Sharp & Dohme
 
Lin Shen
No Relationships to Disclose